Literature DB >> 18390561

A common protamine 1 promoter polymorphism (-190 C->A) correlates with abnormal sperm morphology and increased protamine P1/P2 ratio in infertile patients.

Cristina Gázquez1, Josep Oriola, Sara de Mateo, José M Vidal-Taboada, José Luis Ballescà, Rafael Oliva.   

Abstract

It is known that targeting the protamine 1 gene in mice leads to infertility, abnormal chromatin packaging, and abnormal sperm morphology. Because many infertile patients also have an abnormal sperm morphology and chromatin packaging, the human protamine 1 gene (PRM1) is an important candidate to screen for potential mutations. In this work, we have screened the PRM1 gene in search of potential mutations and determined the sperm morphology and the ratio between protamine 1 and protamine 2 (P1/P2 ratio). Direct sequencing of the PRM1 promoter led to the identification of a common single-nucleotide polymorphism (SNP; -190 C-->A). The -190 AA genotype was detected at a higher frequency (13.8%) in patients with markedly altered sperm morphology (<or=9% normal forms) compared with other patients (4.5%; P < .05) or compared with controls (2.97%; P < .005). The allelic frequency of the PRM1 -190 C-->A change was also consistently higher (.331) in infertile patients with a markedly altered morphology compared with population controls (.178; P < .01). Additionally, we have determined that the P1/P2 ratio is significantly increased in patients with the PRM1 -190 AA genotype compared with patients with the CA or CC genotypes (P = .006, Mann-Whitney). These findings indicate that the common PRM1 -190 C-->A polymorphism identified is associated with abnormal sperm head morphology and abnormal P1/P2 ratio in infertile patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390561     DOI: 10.2164/jandrol.107.004390

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  8 in total

1.  The c.-190 C>A transversion in promoter region of protamine1 gene as a genetic risk factor for idiopathic oligozoospermia.

Authors:  Shirin Jamali; Mohammad Karimian; Hossein Nikzad; Younes Aftabi
Journal:  Mol Biol Rep       Date:  2016-05-23       Impact factor: 2.316

2.  Protamine-1 and -2 polymorphisms and gene expression in male infertility: an Italian study.

Authors:  D Grassetti; D Paoli; M Gallo; A D'Ambrosio; F Lombardo; A Lenzi; L Gandini
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 5.467

3.  Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysis.

Authors:  Weijun Jiang; Hui Sun; Jing Zhang; Qing Zhou; Qiuyue Wu; Tianfu Li; Cui Zhang; Weiwei Li; Mingchao Zhang; Xinyi Xia
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

4.  Polymorphisms in protamine 1 and 2 genes in asthenozoospermic men: A case-control study.

Authors:  Ali Nabi; Mohammad Ali Khalili; Mojgan Moshrefi; Mohammad Hasan Sheikhha; Ehsan Zare Mehrjardi; Hamid Reza Ashrafzadeh
Journal:  Int J Reprod Biomed       Date:  2018-06

5.  Sperm Ribosomal DNA Promoter Methylation Levels Are Correlated With Paternal Aging and May Relate With in vitro Fertilization Outcomes.

Authors:  Lejun Li; Hongping Li; Yonghong Tian; Minhao Hu; Fang Le; Liya Wang; Xiaozhen Liu; Fan Jin
Journal:  Front Genet       Date:  2020-04-03       Impact factor: 4.599

6.  Evaluation of the association between polymorphisms of PRM1 and PRM2 and the risk of male infertility: a systematic review, meta-analysis, and meta-regression.

Authors:  Houshang Nemati; Masoud Sadeghi; Mehri Nazeri; Mohana Mohammadi
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

7.  Association study of six SNPs in PRM1, PRM2 and TNP2 genes in iranian infertile men with idiopathic azoospermia.

Authors:  Elham Siasi; Ahmad Aleyasin; Javad Mowla; Hamid Sahebkashaf
Journal:  Iran J Reprod Med       Date:  2012-07

8.  Polymorphisms of protamine genes contribute to male infertility susceptibility in the Chinese Han population.

Authors:  Weijun Jiang; Peiran Zhu; Jing Zhang; Qiuyue Wu; Weiwei Li; Shuaimei Liu; Mengxia Ni; Maomao Yu; Jin Cao; Yi Li; Yingxia Cui; Xinyi Xia
Journal:  Oncotarget       Date:  2017-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.